Ballmer-Hofer K - Search Results

1

Thermodynamic and structural description of allosterically regulated VEGFR-2 dimerization.

Brozzo MS, Bjelić S, Kisko K, Schleier T, Leppänen VM, Alitalo K, Winkler FK, Ballmer-Hofer K. Brozzo MS, et al. Blood. 2012 Feb 16;119(7):1781-8. doi: 10.1182/blood-2011-11-390922. Epub 2011 Dec 29. Blood. 2012. PMID: 22207738 Free article.

2

Structural determinants of vascular endothelial growth factor-D receptor binding and specificity.

Leppänen VM, Jeltsch M, Anisimov A, Tvorogov D, Aho K, Kalkkinen N, Toivanen P, Ylä-Herttuala S, Ballmer-Hofer K, Alitalo K. Leppänen VM, et al. Blood. 2011 Feb 3;117(5):1507-15. doi: 10.1182/blood-2010-08-301549. Epub 2010 Dec 8. Blood. 2011. PMID: 21148085 Free article.

3

Structural analysis of vascular endothelial growth factor receptor-2/ligand complexes by small-angle X-ray solution scattering.

Kisko K, Brozzo MS, Missimer J, Schleier T, Menzel A, Leppänen VM, Alitalo K, Walzthoeni T, Aebersold R, Ballmer-Hofer K. Kisko K, et al. FASEB J. 2011 Sep;25(9):2980-6. doi: 10.1096/fj.11-185397. Epub 2011 May 25. FASEB J. 2011. PMID: 21613573

4

Functional and structural characterization of the kinase insert and the carboxy terminal domain in VEGF receptor 2 activation.

Manni S, Kisko K, Schleier T, Missimer J, Ballmer-Hofer K. Manni S, et al. FASEB J. 2014 Nov;28(11):4914-23. doi: 10.1096/fj.14-256206. Epub 2014 Aug 11. FASEB J. 2014. PMID: 25114179

5

Structural determinants of growth factor binding and specificity by VEGF receptor 2.

Leppänen VM, Prota AE, Jeltsch M, Anisimov A, Kalkkinen N, Strandin T, Lankinen H, Goldman A, Ballmer-Hofer K, Alitalo K. Leppänen VM, et al. Proc Natl Acad Sci U S A. 2010 Feb 9;107(6):2425-30. doi: 10.1073/pnas.0914318107. Proc Natl Acad Sci U S A. 2010. PMID: 20145116 Free PMC article.

6

Targeting extracellular domains D4 and D7 of vascular endothelial growth factor receptor 2 reveals allosteric receptor regulatory sites.

Hyde CA, Giese A, Stuttfeld E, Abram Saliba J, Villemagne D, Schleier T, Binz HK, Ballmer-Hofer K. Hyde CA, et al. Mol Cell Biol. 2012 Oct;32(19):3802-13. doi: 10.1128/MCB.06787-11. Epub 2012 Jul 16. Mol Cell Biol. 2012. PMID: 22801374 Free PMC article. Review.

7

Structural and mechanistic insights into VEGF receptor 3 ligand binding and activation.

Leppänen VM, Tvorogov D, Kisko K, Prota AE, Jeltsch M, Anisimov A, Markovic-Mueller S, Stuttfeld E, Goldie KN, Ballmer-Hofer K, Alitalo K. Leppänen VM, et al. Proc Natl Acad Sci U S A. 2013 Aug 6;110(32):12960-5. doi: 10.1073/pnas.1301415110. Epub 2013 Jul 22. Proc Natl Acad Sci U S A. 2013. PMID: 23878260 Free PMC article.

8

Structure of the Full-length VEGFR-1 Extracellular Domain in Complex with VEGF-A.

Markovic-Mueller S, Stuttfeld E, Asthana M, Weinert T, Bliven S, Goldie KN, Kisko K, Capitani G, Ballmer-Hofer K. Markovic-Mueller S, et al. Among authors: ballmer hofer k. Structure. 2017 Feb 7;25(2):341-352. doi: 10.1016/j.str.2016.12.012. Epub 2017 Jan 19. Structure. 2017. PMID: 28111021 Free article.

9

ScFvs as Allosteric Inhibitors of VEGFR-2: Novel Tools to Harness VEGF Signaling.

Ballmer-Hofer K, A C Hyde C, Schleier T, Avramovic D. Ballmer-Hofer K, et al. Int J Mol Sci. 2018 May 1;19(5):1334. doi: 10.3390/ijms19051334. Int J Mol Sci. 2018. PMID: 29723982 Free PMC article.

10

Crystal structure of the Orf virus NZ2 variant of vascular endothelial growth factor-E. Implications for receptor specificity.

Pieren M, Prota AE, Ruch C, Kostrewa D, Wagner A, Biedermann K, Winkler FK, Ballmer-Hofer K. Pieren M, et al. J Biol Chem. 2006 Jul 14;281(28):19578-87. doi: 10.1074/jbc.M601842200. Epub 2006 May 3. J Biol Chem. 2006. PMID: 16672228 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

95 results

Search Page

Filters